Stratec SE (ETR:SBS)
27.45
-0.45 (-1.61%)
Nov 16, 2026, 12:34 PM CET
Stratec SE Revenue
Stratec SE had revenue of 52.37M EUR in the quarter ending September 30, 2026, a decrease of -8.12%. This brings the company's total for the last twelve months to 240.18M, down -6.51% year-over-year. In the year 2025, Stratec SE had annual revenue of 250.86M, down -2.62%. That makes Stratec SE the 15,460th largest company in the world by revenue and 278th in Germany.
Revenue (ttm)
240.18M
Revenue Growth
-6.51%
P/S Ratio
1.41
Revenue / Employee
173.67K
Employees
1,383
Market Cap
333.68M
Revenue by Geography
- European Union 102.24M 40.8%
- United States 101.06M 40.3%
- Germany 30.03M 12.0%
- Other 17.54M 7.0%
Fiscal year ended Dec 31, 2025 See the full Stratec SE breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 250.86M | -6.76M | -2.62% |
| Dec 31, 2024 | 257.62M | -12.79M | -4.73% |
| Dec 31, 2023 | 270.41M | -4.21M | -1.53% |
| Dec 31, 2022 | 274.63M | -12.71M | -4.42% |
| Dec 31, 2021 | 287.34M | 37.24M | 14.89% |
| Dec 31, 2020 | 250.10M | 35.94M | 16.78% |
| Dec 31, 2019 | 214.16M | 26.34M | 14.02% |
| Dec 31, 2018 | 187.82M | -19.66M | -9.47% |
| Dec 31, 2017 | 207.48M | 22.57M | 12.20% |
| Dec 31, 2016 | 184.91M | 38.03M | 25.89% |
| Dec 31, 2015 | 146.89M | 2.03M | 1.40% |
| Dec 31, 2014 | 144.86M | 16.91M | 13.22% |
| Dec 31, 2013 | 127.95M | 5.28M | 4.31% |
| Dec 31, 2012 | 122.67M | 6.11M | 5.24% |
| Dec 31, 2011 | 116.56M | 116.46M | 114,197.20% |
| Dec 31, 2010 | 101.98K | 22.39K | 28.13% |
| Dec 31, 2009 | 79.59K | 18.62K | 30.54% |
| Dec 31, 2008 | 60.97K | -6.56K | -9.71% |
| Dec 31, 2007 | 67.53K | -887.00 | -1.30% |
| Dec 31, 2006 | 68.41K | 21.12K | 44.65% |
| Dec 31, 2005 | 47.30K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.77B |
| Siemens Healthineers AG | 23.63B |
| Fresenius SE & Co. KGaA | 23.61B |
| Merck KGaA | 21.44B |
| Medios AG | 2.18B |
| MEDICLIN Aktiengesellschaft | 825.43M |
| Evotec SE | 718.32M |
| Eckert & Ziegler SE | 316.81M |
Stratec SE News
- 3 days ago - Stratec SE Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Stratec SE Quarterly report: Q3 2026 - Filings
- 3 days ago - Stratec SE Earnings release: Q3 2026 - Filings
- 3 days ago - Stratec SE Slides: Q3 2026 - Filings
- 4 days ago - STRATEC Unveils Final Results for First Nine Months of 2026 - Wallstreet:Online
- 16 days ago - STRATEC Sells Loss-Making Unit, Books Impairments, Revises Outlook - Wallstreet:Online
- 16 days ago - EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE - Wallstreet:Online
- 23 days ago - EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online